GlaxoSmithKline PLC Director/PDMR Shareholding (7991D)
30 Ottobre 2020 - 1:53PM
UK Regulatory
TIDMGSK
RNS Number : 7991D
GlaxoSmithKline PLC
30 October 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ==========================================================================================
a) Name Sir Jonathan Symonds
==== ======================================= =================================================
b) Position/status Non-Executive Chairman
==== ======================================= =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================= =================================================
b) Nature of the Sale of 8,944 Ordinary Shares from SIPP
transaction
==== ======================================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ======================== ====================
GBP13.169 8,944
===================================================================== ====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ===========================
e) Date of the transaction 2020-10-29
==== ======================================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ======================================= =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==========================================================================================
a) Name Sir Jonathan Symonds
==== ======================================= =================================================
b) Position/status Non-Executive Chairman
==== ======================================= =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================= =================================================
b) Nature of the Purchase of 15,000 Ordinary Shares
transaction
==== ======================================= =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ======================== ====================
GBP13.154 15,000
===================================================================== ====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ===========================
e) Date of the transaction 2020-10-29
==== ======================================= =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ======================================= =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHLBLFXBBLEFBB
(END) Dow Jones Newswires
October 30, 2020 08:53 ET (12:53 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024
